Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
A clinic that cannot tell you which pharmacy compounded the vial is a clinic that does not control its supply chain
Hanefeld M, Pfutzner A, Forst T, Lubben G
A.et al (2018)
Shaming patients who are overweight or obese has NO place anywhere in medical care, or elsewhere
anti-obesity drug market competition to heat up ADVERTISEMENT India's top drug maker Sun Pharmaceutical Industries has announced today the launch of a generic version of semaglutide, the main ingredient for Novo Nordisk's blockbuster weight-loss drug Wegovy and blockbuster diabetes drug Ozempic, heating the competition in the anti-diabetes and anti-obesity drug market in the country
US$ 25.06
US$ 24.72
US$ 20.73
US$ 27.83
US$ 21.10
US$ 24.70
US$ 28.03
US$ 24.10
US$ 22.09
US$ 22.47
